Isabelle Mosnier
Overview
Explore the profile of Isabelle Mosnier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marx M, Mounie M, Mosnier I, Venail F, Mondain M, Uziel A, et al.
Eur J Health Econ
. 2024 Nov;
PMID: 39562492
Objectives: To determine the Incremental Cost-Utility Ratio (ICUR) of cochlear implantation in the treatment of adult patients with single-sided deafness (SSD) and asymmetric hearing loss (AHL). Methods: This prospective multicenter...
2.
Daoudi H, Torres R, Mosnier I, Ambert-Dahan E, Liagre-Cailles A, Smail M, et al.
Acta Neurochir (Wien)
. 2024 Oct;
166(1):390.
PMID: 39356313
Purpose: This retrospective monocentric study aimed to evaluate long-term auditory brainstem implant (ABI) function in patients with neurofibromatosis type 2, and to investigate the prognostic factors for ABI use. Methods:...
3.
Mosnier I, Belmin J, Cuda D, Manrique Huarte R, Marx M, Macias A, et al.
Front Aging Neurosci
. 2024 Oct;
16:1444330.
PMID: 39355541
Background: Untreated hearing loss has an effect on cognition. It is hypothesized that the additional processing required to compensate for the sensory loss affects the cognitive resources available for other...
4.
Rive Le Gouard N, Lafond-Rive V, Jonard L, Loundon N, Achard S, Heidet L, et al.
Clin Genet
. 2024 Jun;
106(5):564-573.
PMID: 38940299
HDR syndrome is a rare disease characterized by hypoparathyroidism, deafness, and renal dysplasia. An autosomal dominant disease caused by heterozygous pathogenic GATA3 variants, the penetrance of each associated condition is...
5.
Torres R, Daoudi H, Gu W, Breil E, Ferrary E, Sterkers O, et al.
Otolaryngol Head Neck Surg
. 2024 Mar;
171(2):521-529.
PMID: 38532540
Objective: To assess trauma patterns associated with the insertion of lateral wall electrode arrays. The study focused on 3 categories-scala tympani (ST), intermediate, and scala vestibuli (SV)-to identify traumatic patterns...
6.
Flament J, De Seta D, Russo F, Bestel J, Sterkers O, Ferrary E, et al.
Audiol Neurootol
. 2024 Mar;
29(5):408-417.
PMID: 38527427
Introduction: Auditory performance in noise of cochlear implant recipients can be assessed with the adaptive Matrix test (MT); however, when the speech-to-noise ratio (SNR) exceeds 15 dB, the background noise...
7.
Grenier B, Mosnier I, Ferrary E, Nguyen Y, Sterkers O, Kalamarides M, et al.
Otolaryngol Head Neck Surg
. 2024 Mar;
171(1):218-230.
PMID: 38482961
Objective: To evaluate long-term hearing outcomes following cochlear implantation in patients with neurofibromatosis type 2 and ipsilateral vestibular schwannoma. Study Design: Retrospective study. Setting: Tertiary general hospital. Methods: Twenty-two patients...
8.
Di Bari M, Law-Ye B, Bernardeschi D, Lahlou G, Sterkers O, Colombo G, et al.
Eur Arch Otorhinolaryngol
. 2023 Oct;
281(4):1789-1798.
PMID: 37906365
Purpose: The study aimed to evaluate the long-term clinical, radiological, and functional results for subtotal petrosectomy and cochlear implant surgery with closure of the external auditory canal and fat obliteration....
9.
Gu W, Daoudi H, Lahlou G, Sterkers O, Ferrary E, Nguyen Y, et al.
Eur Arch Otorhinolaryngol
. 2023 Jul;
281(1):155-162.
PMID: 37516989
Purpose: In cochlear implantation, a scala vestibuli (SV) insertion of an electrode array is a rare occurrence and is reported to be linked to poor hearing outcomes. Using the same...
10.
Goderie T, Hendricks S, Cocchi C, Maroger I, Mekking D, Mosnier I, et al.
Otol Neurotol
. 2023 Jun;
44(7):e449-e455.
PMID: 37317476
Objective: The aim is to recommend a minimum standard set of clinician-reported outcome measures (CROMs) and patient-reported outcome measures (PROMs) on hearing for people with osteogenesis imperfecta (OI). This project...